Tasker Sybil 4
4 · Altimmune, Inc. · Filed May 23, 2018
Insider Transaction Report
Form 4
Tasker Sybil
Chief Medical Officer
Transactions
- Award
Stock Options (option to buy)
2018-05-21+50,016→ 50,016 totalExercise: $0.45Exp: 2028-05-21→ Common Stock, par value $0.0001 (50,016 underlying)
Footnotes (1)
- [F1]Twenty-five percent of the option becomes vested and exercisable on March 1, 2019, and the aggregate unvested remaining portion will vest and become exercisable in equal monthly installments on the first day of each month over the 36-month period starting April 1, 2019.